Russell Barton
Direttore operativo presso ACUMEN PHARMACEUTICALS, INC.
Patrimonio netto: 309 006 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Russell Barton
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD.
7
| Holding Company | Biotechnology | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Russell Barton tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CELGENE | Biotechnology | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
NatWest Markets Securities, Inc.
 NatWest Markets Securities, Inc. Investment Banks/BrokersFinance Founded in 1985, NatWest Markets Securities, Inc. is a financial services and brokerage firm headquartered in Stamford, Connecticut. The firm is a subsidiary of RBS Holdings USA, Inc. and their ultimate parent is the Royal Bank of Scotland Plc (LSE: RBS). The firm was formerly known as RBS Securities, Inc., RBS Greenwich Capital, and Greenwich Capital Markets, Inc. NatWest is an institutional fixed-income firm that provides a full range of debt capital markets services to both those seeking to raise capital and those seeking to invest it. The firm is an industry leader in the U.S. Treasury, agency and MBS markets and in providing real estate and asset-backed financing to their clients. NatWest also provides futures brokerage services and trade strategies to select clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | General Counsel Portfolio Manager-Equities | |
| Octagon Partners LLC | Corporate Officer/Principal | ||
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Biotechnology | Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| Connecticut College | College/University | Undergraduate Degree | |
| Indiana University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The Johns Hopkins University | College/University | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
| University of Delaware | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| Georgetown University | College/University | Doctorate Degree | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens. | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
Alzheimer’s Association
 Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is based in Chicago, IL and has subsidiaries in the United States. The Alzheimer's Association provides information and resources for Alzheimer's and other dementias. Alzheimer’s Association was founded in 1980. Joanne Pike has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| CS First Boston Pacific, Inc. | Corporate Officer/Principal | ||
AstraZeneca Pharmaceuticals AB
 AstraZeneca Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceuticals AB is a Swedish pharmaceutical company. The company is based in Södertälje, Sweden. The company's description could not be retrieved due to an error. | Pharmaceuticals: Major | Director/Board Member | |
Enterprise Mortgage Acceptance Co. LLC
 Enterprise Mortgage Acceptance Co. LLC Miscellaneous Commercial ServicesCommercial Services Enterprise Mortgage Acceptance Co. LLC provides capital and financing options for equipment financing and business loans. The private company is based in Westport, CT and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Benevolent Capital Partners LLC (Private Equity)
 Benevolent Capital Partners LLC (Private Equity) Investment ManagersFinance Benevolent Capital Partners LLC (Private Equity) (Benevolent Capital) is a private equity and venture capital firm founded in 2005 by Brett M. Johnson and Grant D. Johnson. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Founder | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| The Indiana University School of Medicine | College/University | Doctorate Degree | |
| Huntington Study Group | Director/Board Member | ||
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
| Neuropharma Advisors LLC | Corporate Officer/Principal | ||
Astrocyte Pharmaceuticals, Inc.
 Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Octagon Finance LLC
 Octagon Finance LLC Financial ConglomeratesFinance Octagon Finance LLC provides financial services. The private company is based in Durham. | Financial Conglomerates | Corporate Officer/Principal | |
| Novartis Gene Therapies Switzerland GmbH | Director/Board Member | ||
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member | |
| BrightFocus Foundation, Inc. | Director/Board Member | ||
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
| Baxis Pharmaceuticals, Inc. | Director/Board Member | ||
| Vetana Animal Health, Inc. | Director/Board Member | ||
| Seimers Integration LLC | President | ||
| Ravelin Capital Group LLC | Corporate Officer/Principal | ||
| ALKERMES PLC | Pharmaceuticals: Major | Investor Relations Contact |
Statistiche
Distribuzione geografica
| Stati Uniti | 48 |
| Svezia | 2 |
| Svizzera | 2 |
| Irlanda | 2 |
Settori
| Health Technology | 18 |
| Consumer Services | 11 |
| Finance | 10 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 78 |
| Corporate Officer/Principal | 71 |
| Undergraduate Degree | 23 |
| Independent Dir/Board Member | 18 |
| Director of Finance/CFO | 16 |
Contatti più connessi
| Insiders | |
|---|---|
| Matthew Zuga | 32 |
| Sean Stalfort | 28 |
| Kimberlee Drapkin | 23 |
| Ronald M. Nordmann | 16 |
| Derrell Porter | 14 |
| Jeffrey Ives | 13 |
| Charles I. Clarvit | 11 |
| Daniel O'Connell | 11 |
| Laura Stoppel | 9 |
| Jeffrey Sevigny | 9 |
| Derek Meisner | 8 |
| Eric Siemers | 8 |
| Nathan Fountain | 7 |
| Grant A. Krafft | 6 |
| Jim Doherty | 6 |
- Borsa valori
- Insiders
- Russell Barton
- Connessioni Società
